Vulvar malignant melanoma: a case report and review of its management
https://doi.org/10.4081/dr.2022.9345
Accepted: 4 March 2022
HTML: 205
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Vulvar malignant melanoma (VMM) is uncommon and poses a significant management challenge. Here, we presented a case of VMM managed by surgery, chemoradiation, and planned for targeted therapy. A 70-year-old woman with underlying diabetes mellitus and hypertension presented with a black-colored exophytic growth around her left vulva for two months. Initial biopsy confirmed malignant melanoma with positive staining for S100, HMB 45, and Melan A. An imaging study showed that the disease was localized to the vulva. She underwent bilateral radical vulvectomy and bilateral inguinofemoral lymph node dissection followed by radiotherapy. She had a locoregional disease recurrence, which was subsequently managed by palliative perineal radiotherapy, chemotherapy, and planned for immunotherapy. Vulvar malignant melanoma is a rare and aggressive tumor, with a poor overall prognosis, and high recurrence rate. Adjuvant chemotherapy, radiotherapy, and immunotherapy may be beneficial for local recurrence and distant metastasis cases. Molecular Analysis has a potential role in targeted therapy to improve the survival and outcome of the patient.
ul Ain, Q. and B. Rao, A rare case report: malignant vulvar melanoma. Indian J Gynecol Oncol 2020;18:1-4.
Seifried S, et al., Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases. Ann Surg Oncol 2015;22:1959-66.
Boer FL, et al., Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature. Cancer Treat Rev 2019;73:91-103.
Wohlmuth C, Wohlmuth-Wieser I. Vulvar malignancies: an interdisci-plinary perspective. J Dtsch Dermatol Ges 2019;17:1257-76.
Khaba MC, Lekala ML, Mosehle SD. Malignant nodular melanoma of the vulva: a rare and aggressive tumour of the female genital tract (case report). Pan Afr Med J 2021;38.
Gungor T, et al. Primary malignant melanoma of the female genital tract. Taiwan J Obstet Gynecol 2009;48:169-75.
Sinasac SE, et al. Melanoma of the vulva and vagina: surgical management and outcomes based on a clinicopatho-logic reviewof 68 cases. J Obstet Gynaecol Canada 2019;41:762-71.
Leitao Jr MM. Management of vulvar and vaginal melanomas: current and future strategies. Am Soc Clin Oncol Educat Book 2014;34:e277-81.
Yuan G, et al. Analysis of treatment and prognosis of 59 cases of vulvar melanoma. Zhonghua fu Chan ke za zhi 2020;55:395-401.
Janco JMT, et al. Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy. Gynecol Oncol 2013;129:533-7.
Baiocchi G, et al. Vulvar melanoma: report on eleven cases and review of the literature. Sao Paulo Med J 2010;128:
- 41.
Wohlmuth C, et al. Malignant melanoma of the vulva and vagina: a US population-based study of 1863 patients. Am J Clin Dermatol 2020;21:285-95.
Copyright (c) 2022 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
